Decibel Therapeutics to Present at the Jefferies Global Healthcare Conference
03.06.2022 - BOSTON, June 03, 2022 (GLOBE NEWSWIRE) - Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced that ...
Julie Seidel Chris Railey Stern Investor Relations Inc About Decibel Decibel Therapeutics Investor Relations
Source: wallstreet-online.de